Psychiatry SC076: I Cannot Help Myself, Taking These Pills Just Feels Good: Substance Abuse And Addiction Flashcards

1
Q

Addiction

A
  • Attachment to (Psychological) / Dependence upon (Psychological / Physiological)
  • On any substance, thing, person, idea
  • So single-minded + intense that virtually all other realities are ignored / given second place and consequences (even lethal ones) are disregarded

Terminology:
1. Problem use / Misuse
- Use for pleasure but with ***disregard for personal / social dangers

  1. Craving
    - Strong + Irresistible ***desire
    - Not necessarily pleasurable
  2. Dependence (Physical / Psychological)
    - Physical adaptation —> **Physical withdrawal symptoms
    - **
    Psychological withdrawal symptoms
  3. Addiction
    - ***Extreme end of dependent spectrum
    - Social + Personal decline, tolerance, withdrawal symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dependence syndrome ICD-10 criteria

A
  1. A strong desire or sense of ***compulsion to take the substance
  2. Difficulties in controlling substance taking behaviour in terms of its onset, termination, or levels of use
  3. A physiological ***withdrawal state when substance use has ceased or been reduced
  4. Evidence of ***tolerance
  5. Progressive neglect of alternative pleasures or interests
  6. ***Persisting with substance use despite clear evidence of overtly harmful consequences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Substances being abused

A
  1. Alcohol
  2. Opioids (e.g. ***heroin, morphine, codeine, methadone)
  3. ***Cocaine (e.g. cocaine, crack)
  4. ***Amphetamines
  5. Sedative, hypnotics, anxiolytics
  6. Hallucinogens (e.g. LSD, ecstasy)
  7. Phencyclidine (e.g. PCP, ketamine)
  8. Inhalants
  9. ***Cannabis
  10. Nicotine
  11. Caffeine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Biological basis of addiction

A

Start off with Occasional use —> Addicted / Become habit

Occasional use:
- ***Impulsive act
—> Increase sense of arousal + sense of tension before the act (i.e. Positive reinforcement)

Addicted / Become habit:
- ***Compulsive act
—> Anxiety / Stress before + Relief after the act (i.e. Negative reinforcement)

Principles of reinforcement:
- Reinforcer: increase likelihood of a behaviour that precedes its presentation
- Positive reinforcement: Positive outcomes follows the behaviour (e.g. award)
- Negative reinforcement: Behaviour supported by avoidance / termination of aversive events (e.g. punishment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

***Stage of addiction

A

Binge intoxication (↑ reward circuits: VTA, NA) (**Impulsive stage)
—> Drug reinforcement + Further intoxication (↑ reward circuits: VTA, NA)
—> Withdrawal + Tolerance (↓ reward circuits: Anterior cingulate, Prefrontal cortex, Amygdala, changes in synapse / synaptic receptor —> downregulation of D2 receptors)
—> Craving / Preoccupation / Relapse (Amygdala for **
conditional response, Hippocampus for **memory, Prefrontal cortex, Orbitofrontal cortex for **executive function) (Act is no longer pleasurable —> ***Compulsive stage)
—> Binge intoxication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Neurotransmitter in Addiction

A

Primary neurotransmitter:
1. Glutamate (Stimulatory)
2. GABA (Inhibitory)
—> Action, Sensation, Learning, Memory

Secondary neurotransmitter:
1. Dopamine
2. Noradrenaline
3. Serotonin
4. Acetylcholine
5. Endogenous opiate
6. Endogenous cannabinoid

Endogenous “addictive” neurotransmitter:
- Opioid peptides (e.g. Endorphins)
- Endogenous cannabinoids (e.g. Anandamide)
—> suggest a lot of pleasurable activities (e.g. eating, exercise) are involved in a reward system

All drugs have interaction with neurotransmitter:
- Mimic natural transmitter
- Release transmitter
- Block transmitter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dopaminergic system

A
  1. Cognition
    - Schizophrenia
    - Parkinson’s disease
    - Attention deficit
  2. Motor
    - Parkinson’s disease
  3. Reward learning
    - Drug abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Reward pathway

A

**Mesolimbic dopamine system
- Dopamine from VTA (ventral tegmental area) —> Nucleus accumbens + Amygdala —> Prefrontal cortex
- Activation + Positive reinforcement effect
- Drug of abuse increase Dopamine activity in **
Nucleus accumbens

Nucleus accumbens:
- Area for desire

Amygdala:
- Emotion

Hippocampus:
- Come later in stage of addiction

  • ALL drugs of abuse activate Mesolimbic dopamine system
  • Dopamine independent reinforcement occurs at the level of ***Nucleus Accumbens (e.g. cannabinoids CB1, serotonin (opiates increase 5HT in NA))
  • When reinforcers are too powerful, natural drives (e.g. eating, work, sex) may be subsumed —> ignored
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tolerance and Withdrawal

A

Neuroplasticity:
- Adaptations in receptors + post-receptor mechanisms (e.g. change number of receptors) —> Tolerance

Withdrawal:
- Activation of extended ***Amygdala
- Major neurotransmitters: CRF, NE
- Major projection: Hypothalamus, Brainstem —> Physical symptoms of withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Craving / Preoccupation / Relapse

A

Key element of relapse in human:
1. Drug seeking induced by drug / stimuli paired (i.e. cue e.g. seeing the needle) with drug taking
2. Drug seeking induced by an acute stressor / a residual negative emotional state, often a state of stress (aka protracted abstinence)

Neurobiology:
- Conditional reinforcement in **Amygdala (associated with emotion)
- Contextual information processing by **
Hippocampus
- Executive control depends on **Prefrontal cortex (ability to inhibit emotion / control activity)
- Major neurotransmitter: **
Glutamate

Relapse:
- Strong conditional reinforcement + A lot of contextual information + Impaired executive control —> Push towards Relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Personality + Environmental involvement in Substance abuse

A

Controversial:
- Sensation seeking
- Impulsive
- More extrovert
—> Predispose to experiment with licit / illicit drugs

  • Obsessional
  • Dependent
  • Anxious
    —> More likely to get dependent + difficult to stop

Animal experiment:
- Socially housed
- More dominant
—> More D2 receptors in brain, less likely with cocaine use

  • Individually housed
  • More subordinate
    —> Less D2 receptors in brain, more likely with cocaine use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Assessment of Substance abuse

A

Aims of assessment:
1. Make diagnosis
- Differentiating the drug using problem

  1. Formulation (What, Why, How)
    - Understand the problems/difficulties (**Impact)
    - Understand the **
    needs
    - Understand the **person
    - **
    Why the patient take drugs?
  2. Facilitating treatment plan
    - Based on ***Stage of changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Make diagnosis
A
  1. Based on diagnostic criteria
    - Tolerance
    - Withdrawal (physical / psychological)
    - Compulsion of act
  2. Drug screening / testing
  3. Tools e.g. **CAGE as screening questionnaire for alcohol misuse
    - Have you ever felt you should **
    cut down on drinking?
    - Have people **annoyed you by criticising your drinking?
    - Have you ever felt bad / **
    guilty about your drinking?
    - Have you ever had a drink first thing in the morning to steady your nerves / get rid of hangover? (i.e. **Eye-opener)
    —> **
    >=2 positive indicate positive test —> further assessment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Formulation (What, Why, How)
A

Impact:
1. **Medical impact
(Faster the drug reach their target site in the brain: better they are liked + more psychologically reinforcing)
- Impact of **
Route (i.e. on body)
—> Ingestion
—> Inhalation / Smoking
—> Injection (SC, IM, IV)
- Impact of **Form / Substances (state of intoxication / withdrawal)
- Impact of **
Chronic use
- Impact on ***Self care

  1. Psychological impact
    - ***Comorbid mental health problems
    —> Anxiety
    —> Depression
    —> Psychosis
    - Motivational problems
    - Insomnia
  2. Social impact
    - Relationship
    - Housing
    - Work
    - Finance
    - Criminal activity

Needs (Patient’s subjective needs + Doctor’s thought on patient’s needs):
1. Medical
2. Psychological
3. Social

Person:
1. Personality
2. Resources (∵ stressors is an important triggering factor for relapse)
—> Coping methods
—> Support network
3. Other problems
4. Subjective understanding, views, needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why the patient take drugs?

A
  • Important part of assessment ∵ lead to effective treatment
    —> Indicate future trigger factor for relapse

Reason can be dynamic (i.e. change over time)
1. High and buzz, Pleasure seeking (20%)
2. Self-medication for anxiety (social anxiety, anger, pain, boredom, lack of confident, lack of motivation etc.)
3. Psychiatric problem: depression, SE of some drugs, anxiety-related problems
4. Social pressure: peer effect, life events, adversity
5. Search for meaning / mystical experiences (e.g. connect to spiritual world)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stages of change: Prochaska + Diclemente

A

Pre-contemplation
—> Contemplation
—> Preparation
—> Action (where clinicians need to push the patient to)
—> Maintenance (need to identify triggers to relapse + help the patient to avoid these)
—> Relapse

17
Q

SpC Psychiatry: History taking in Substance abuse

A

Questions to ask (Subjective + Objective):
1. 有無越食越多 (Subjective)
2. What can you give up / has done in order to get a substance? (Objective)
3. Physical / Psychological withdrawal symptoms
4. Functional impairment
5. Dependence features
- Primacy
- Stereotype pattern
6. Any time of serious consequences / complications
- Psychosocial (e.g. dangerous driving / activities leading to incident, forensic events)
- Psychiatric
- Physical (e.g. HBV, nasal septal perforation due to inhalation, medical complications leading to hospitalisation (e.g. hallucinations)
7. Any change of ways of taking the substance

Typical history of substance abuse person:
1. Long history of substance abuse
2. Polysubstance
3. Key time points
- When first started (What made them use it in the first place)
- Time when patient start to use everyday / on regular basis
- Time difference between first start and doing regularly —> Reflection of devotion
- When started to want to quit
—> Factors that motivate / trigger them to want to quit
—> Methods used to quit
- Relapse —> What cause them to restart on substance
- Last consumption

18
Q

Stimulants, Tranquilisers, Narcotic analgesics, Hallucinogens

A

Stimulants (興奮劑):
- Cocaine (可卡因)
- Amphetamine (冰)
- MDMA (搖頭丸)
- Nicotine
- Phencyclidine / Ketamine (K仔) (Indirect stimulant)
(Withdrawal: Post-use “crash” —> depression, anxiety, suicidal ideation, intense cravings, lethargy, headache, insomnia / hypersomnia) (Ryan Ho)

Tranquilisers (鎮靜劑):
- Alcohol
- Benzodiazepine (BDZ)
(Withdrawal: Sympathetic activation: sweating, tachycardia, hypertension, piloerection, insomnia, rebound anxiety, seizure) (Ryan Ho)

Narcotic analgesics (麻醉鎮痛劑):
- Opiates (e.g. Heroin, Morphine, Opium, Methadone)

Hallucinogens (迷幻劑):
- Cannabis (大麻)
- LSD
(Withdrawal: Less withdrawal symptoms) (Ryan Ho)

19
Q

Cocaine

A

Route:
- Smoking
- Snorting
- IV

Acute effect:
1. **Block reuptake of dopamine —> **↑ dopamine at synapses —> **Euphoria, Disinhibition
- Mesocorticolimbic pathway
- Acute reinforcing properties
2. **
Sympathetic NS activation —> ***Autonomic symptoms (can be lethal if have underlying medical comorbidity e.g. CVS disease)

Chronic effect:
- ↓ Sensitivity of dopamine auto-receptors
- Change of post-synaptic receptors + second messenger system
- Tolerance
- Intermittent —> Sensitization vs Continuous —> Tolerance

Withdrawal effect:
- ***Hypoactivity of dopamine system —> less sensitive reward system —> dysphoria, anhedonia, anxiety, fatigue, craving, depression, suicidal ideation (Ryan Ho)

Intoxication (Ryan Ho):
- BDZ +/- Phentolamine

20
Q

Amphetamine

A

Route:
- Oral

Acute effect:
1. **Direct stimulation of release of dopamine (independent of neuronal activity)
2. **
Block dopamine reuptake at MCLP
- More potent in ↑ dopamine —> ***Positive Psychotic symptoms
- Direct stimulate release of NE, E, serotonin

Chronic effect:
- Sensitization: augmentation of dopamine release
- Tolerance: depletion of stored neurotransmitter

Withdrawal (Ryan Ho):
- Depression symptoms (e.g. anhedonia, anergia, low mood, poor concentration, insomnia / hypersomnia, suicidal ideation)

21
Q

Nicotine

A

Route:
- Smoke

Acute effect:
- **Nicotine receptor, one of acetylcholine subtype
- **
Stimulate dopamine release **modest, at MCLP —> **Weak stimulant
- Week reinforce
- Also affect NE, serotonin

Chronic effect:
- Tolerance
- Withdrawal

22
Q

Phencyclidine / Ketamine

A

Route:
- Smoke
- Oral
- IV

Acute effect:
- **NMDA receptor antagonist (a glutamate receptor) —> **↓ GABA inhibitory effect (∴ not a typical stimulant, works indirectly) —> **↑ dopamine release
- **
Direct stimulation of dopamine
- ***Distortion of perceptual experience, derealisation / depersonalisation experience (“unreal”)
- Elevated mood but not euphoria like cocaine / amphetamine

Chronic effect:
- Tolerance (***Negative symptoms)
- Withdrawal (lack of clear symptoms in human)

23
Q

Alcohol

A
  • No known receptor system
  • Affects Ca, Cl channels
  • **Inhibits excitatory receptors + **Augments activity at inhibitory receptors

Acute effect:
- Wide range of receptors are involved
1. **Increase MCLP dopamine
2. **
↑ GABA activity —> ↓ inhibition of other inhibitory neurons —> sedation

Chronic effect:
- Tolerance (Down-regulation of GABA)
- Withdrawal: Alcohol induced alterations in sensitivity of GABA + glutamate —> **CNS hypersensitivity —> **Delirium, Seizure, Encephalopathy

24
Q

Benzodiazepine (BDZ)

A

Route:
- Oral
- IV

Acute effect:
- ***↑ GABA activity —> Inhibitory effect by binding to BDZ receptor coupled with GABAa receptor —> ↑ Cl channel opening

Chronic effect:
- Tolerance: ↓ GABA activity
- Withdrawal (~Alcohol withdrawal)

25
Q

Opiates

A

Route:
- Smoke
- IV

Acute:
- Mimic **endogenous opioid peptide neurotransmitters
- Opioid receptors: Mu, Delta, Kappa
- **
Inhibitory effect on activation of neurons
- **Inhibition of GABA —> **↑ dopamine neurons activity in VTA

Chronic:
- Tolerance (decrease after being clean —> if take same dose prior to clean —> overdose —> cardiac sudden death)
- Withdrawal
—> sympathetic activation, flu-like S/S (Ryan Ho)

26
Q

Cannabis

A

Route:
- Smoke
- Oral

Acute effect:
1. Cannabinoid delta-9-tetrahydrocannabinol (THC): Agonist at CB1 (CNS), CB2 —> ↓ GABA —> ↑ dopamine release (may have psychotic symptoms)
2. **
Cannabidiol (
CBD): Antagonist of CB1 —> **Calming effect
- Organic cannabis: contain both THC + CBD —> effect balance out
- Commercial cannabis: only THC (concentrated)

(CB1, 2: new neurochemical system still not well understood)

Chronic:
- Tolerance
- Mild withdrawal

Can dissolve in adipose tissue, long t1/2
- One dose t1/2: 1 week
- Chronic history: need ~1 month to metabolise

27
Q

Lysergic Acid Diethylamide (LSD)

A

Route:
- Oral

Acute effect:
- ***Serotonin system, particularly on autoreceptor

(from Web:
- Dorsal Raphe, binding the 5HT2A receptor as a partial agonist + 5HT1A as an agonist
- VTA at higher doses, by stimulating dopamine D₂, Trace Amine Associate receptor 1 (TAAR₁) and 5-HT2A)

Chronic effect:
- Tolerance
- No evidence of withdrawal (flashback)

28
Q

Non-pharmacological treatment for Substance abuse (SpC Psychi PP)

A

Dialectical behavioural therapy